Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.9%

1 terminated out of 34 trials

Success Rate

92.9%

+6.4% vs benchmark

Late-Stage Pipeline

18%

6 trials in Phase 3/4

Results Transparency

15%

2 of 13 completed with results

Key Signals

2 with results93% success

Data Visualizations

Phase Distribution

32Total
Not Applicable (24)
Early P 1 (1)
P 1 (1)
P 3 (2)
P 4 (4)

Trial Status

Completed13
Unknown10
Recruiting5
Not Yet Recruiting3
Active Not Recruiting2
Terminated1

Trial Success Rate

92.9%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (34)

Showing 20 of 20 trials
NCT07452614Not ApplicableRecruiting

Predicting Vital Pulp Treatment Outcomes in Symptomatic Pulpits Using Metabolic Biomarker

NCT07302438Not ApplicableNot Yet RecruitingPrimary

Comparative Evaluation of Calcium Silicate-doped Treated Dentin Matrix and Mineral Trioxide Aggregate as Miniature Pulpotomy Biomaterials in Deep Carious Lesions

NCT07391124Not ApplicableActive Not Recruiting

In Vivo Pulp Thermal Changes During Different Slenderization Techniques

NCT06433297Not ApplicableRecruiting

Comparative Evaluation of Indirect vs. Direct Pulp Capping in Deep Carious Mandibular Molars

NCT07300124Not ApplicableNot Yet RecruitingPrimary

Outcome of Direct Pulp Capping and Partial Pulpotomy in Reversible Pulpitis

NCT06936553Completed

Comparison of IL-8, FGF-1 and VEGF Levels in Pulpal Tissue, GCF and Dentinal Fluid Samples of Healthy, Reversible and Irreversible Pulpitis Diagnosed Teeth

NCT07261761Not ApplicableCompletedPrimary

Cytokines as Diagnostic Markers of Pulpal Inflammation and Their Impact on the Outcome of Vital Pulp Therapy

NCT07114198Early Phase 1CompletedPrimary

Pain Management in Teeth With Reversible Pulpitis

NCT07147036Not ApplicableCompletedPrimary

Effectiveness of Biodentine v/s Calcium Hydroxide as Indirect Pulp Capping Materials

NCT07101068Not ApplicableRecruiting

Assessment of Pain and Anxiety During Infiltration Anesthesia Using Dental Anesthesia Injector Versus Conventional Syringe in Pediatric Patients

NCT07073573Not ApplicableActive Not RecruitingPrimary

Evaluation of Pulpal Biomarkers in Vital Pulp Therapy

NCT06874088Not ApplicableCompletedPrimary

Clinical and Radiographic Outcomes of Pulpotomy in Teeth with Different Symptoms and Root Stages

NCT06844448Recruiting

The Effect of Different Risk Factors on the Success Rate of VPT

NCT06675058Not ApplicableNot Yet Recruiting

Caries Location and Its Effect on the Success Rate of Indirect Pulp Treatment in Primary Molars

NCT06435065Phase 4RecruitingPrimary

Direct Pulp Capping Agent on Human Pulp Tissue

NCT05878249Not ApplicableUnknownPrimary

Role Of Wound Lavage in Direct Pulp Capping Of Permanent Teeth With Carious Exposure

NCT05167123Phase 4Completed

Pulp Capping in Primary Molars Using TheraCal (LC)

NCT05144711Not ApplicableUnknown

Management of Deep Carious Lesions in Adults

NCT04167943Phase 3CompletedPrimary

Conservative Pulp Therapy of Primary Molars Using TheraCAL

NCT04617600Not ApplicableUnknownPrimary

Survival Rate After TheraCal PT Pulpotomy Versus MTA Pulpotomy in Children With Vital Primary Molars.

Scroll to load more

Research Network

Activity Timeline